ORIC-944 is a selective, orally active, allosteric inhibitor targeting the EED subunit of polycomb repressive complex 2 (PRC2). ORIC-944 is synergistic with androgen receptor pathway inhibitors (ARPIs) for the study of metastatic prostate cancer.
Molecular Weight:
456.51
Purity:
>99.0%
CAS Number:
[2369769-29-7]
Formula:
C26H25FN6O
Target:
PRC2/EED
* VAT and and shipping costs not included. Errors and price changes excepted